Investing in the Future of Health & Innovation
White Manna Capital Partners is a life sciences and healthcare-focused hedge fund committed to transforming biotech and pharma innovation into meaningful returns.
Explore Our Strategy
Where Healthcare Innovation Meets Investment Intelligence
We specialize in identifying and capitalizing on emerging trends in biotech, pharma, medtech, and diagnostics. Our investment team combines deep domain expertise with disciplined financial rigor to generate alpha across market cycles.
Our Investment Edge
At White Manna Capital Partners, we don't just invest—we anticipate, innovate, and accelerate value in the life sciences sector.
Our edge is rooted in three key principles:
Deep Sector Expertise
We know the science. We speak the language. We see around corners.
White Manna is led by seasoned professionals with decades of experience across biotech, pharma, and healthcare investing. Our leadership has served at the intersection of science, strategy, and capital—giving us unmatched insight into clinical development timelines, regulatory risk, market dynamics, and emerging technologies.
Information Advantage
Where others rely on public data, we generate private intelligence.
We leverage a proprietary network of industry insiders, thought leaders, and domain experts—including medical affairs professionals, regulatory strategists, clinical operators, and payer market advisors. Combined with our AI-enhanced due diligence models, this allows us to uncover opportunities and risks before they surface in the broader market.
Strategic Capital Deployment
We're not chasing hype—we're building conviction.
White Manna invests with precision and purpose. We identify catalysts and inflection points—clinical readouts, regulatory milestones, partnership triggers—and position accordingly. Our portfolio is built around asymmetric risk/reward profiles, with a disciplined focus on downside protection and long-term value creation.
The Result?
Outperformance rooted in insight—not speculation.